Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like MilliporeSigma Introduces Next-Generation High-Sensitivity Protein Detection Platform April 2, 2017 Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech July 23, 2017 Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech February 11, 2018
